i dont think it is to do with BSL contracts
was just looking at he 'outlook' statement
"Following the sale of USM and the sell down of TSI Fund, an earnings gap will exist while opportunities
are pursued to reinvest the proceeds from these transactions. The Company plans to reinvest the
proceeds during the second half of FY12.
The Company is targeting an absolute growth rate of up to 5% in operational NPAT (pre-amortisation)
in FY12. However, excluding the USM and TSI Fund (RAC) contributions from FY11, the year on year
pre-amortisation NPAT growth rate is expected to be 25%. These growth targets are based on
USD/AUD parity and are subject to no deterioration in economic conditions"
From what I can gather the company has sold tsi and usm which are income generating assets.
now what they have is lot of cash sitting in bank earning interest or a low return
So what they are hoping to do is reinvest it in something which will give a higher return.
Anyway that is what they appear to be saying.
They may however might be expecting things to go bad and they are subsequently getting some cash together in case of a credit squeeze and they can't get money to refinance existing facilities.
depends if you take what they say on board or you are bit cynical about things
- Forums
- ASX - By Stock
- TSE
- $3 is always my buy signal
$3 is always my buy signal, page-16
-
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSE (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online